These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 240047)

  • 21. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
    Schassan HH; Witt U
    Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA; Farrell W; Maskell J; Williams JD
    Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The resistance of recent clinical isolates against isepamycin, other aminoglycosides and injectable beta-lactams].
    O'Hara K; Nakamura A; Sawai T; Hosino K; Iwai Y; Nakamura S; Seto I
    Jpn J Antibiot; 2000 Jan; 53(1):46-59. PubMed ID: 10709145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M; Brun Y; Forey F; Fleurette J
    Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the antibacterial effects of gentamycin, tobramycin, dibekacin and amikacin in urinary germs].
    Rothenberger K; Friesen A; Streifinger W; Hofstetter A
    Fortschr Med; 1981 Oct; 99(40):1669-72. PubMed ID: 7298004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro susceptibility of clinically important bacteria to amikacin: correlation of results of broth dilution and disk sensitivity tests and effect of medium composition.
    Linzenmeier G; Naumann P; Neussel H; Rosin H
    J Infect Dis; 1976 Nov; 134 SUPPL():S262-70. PubMed ID: 825584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of sisomicin, an aminoglycoside antibiotic, against clinical isolates.
    Stewart D; Bodey GP
    J Antibiot (Tokyo); 1975 Feb; 28(2):149-55. PubMed ID: 234415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibacterial activity of a new semisynthetic aminoglycoside antibiotic amikacin (BB-K8) (author's transl)].
    Mitsuhashi S; Kawabe H; Iyobe S; Tanaka T; Inoue M
    Jpn J Antibiot; 1974 Apr; 27(2):189-92. PubMed ID: 4211300
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
    Ronco E; Migueres ML; Vacheron F; Guenounou M
    Pathol Biol (Paris); 1988 May; 36(5):430-4. PubMed ID: 3043339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
    Al-Asadi MJ; Towner K; Greenwood D
    J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UK31214, a new aminoglycoside and derivative of kanamycin B.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1980 Mar; 17(3):298-301. PubMed ID: 6775590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.
    Briedis DJ; Robson HG
    Antimicrob Agents Chemother; 1976 Oct; 10(4):592-7. PubMed ID: 825032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Nov; 134 SUPPL():S297-307. PubMed ID: 825588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1977 May; 11(5):791-6. PubMed ID: 879733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.
    Acar JF; Witchitz JL; Goldstein F; Talbot JN; Le Goffic F
    J Infect Dis; 1976 Nov; 134 SUPPL():S280-5. PubMed ID: 825587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD; Steffens A; Langmaack H
    Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro comparison of kanamycin, kanendomycin, gentamicin, amikacin, sisomicin, and dibekacin against 200 strains of Pseudomonas aeruginosa.
    Paradelis AG; Douboyas J; Stathopoulos G; Grigoriadou-Edipides A; Triantaphylidis C; Papapanagiotou J
    Antimicrob Agents Chemother; 1978 Sep; 14(3):514-5. PubMed ID: 101135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.
    Price KE; DeFuria MD; Pursiano TA
    J Infect Dis; 1976 Nov; 134 SUPPL():S249-61. PubMed ID: 62814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ["In vitro" determination of bacterial sensitivity to tobramycin (author's transl)].
    Talon D; Michel-Briand Y
    Pathol Biol (Paris); 1976 Jan; 24(1):25-30. PubMed ID: 817253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.